CEDAR researcher: Joshua Moreau, Ph.D.
Moreau’s lab has found promising research on a type of immune cell, the memory B cell, that could act as a therapeutic target for cancer.
Moreau’s lab has found promising research on a type of immune cell, the memory B cell, that could act as a therapeutic target for cancer.
Franca is a core faculty member in the Knight Cancer Precision Biofabrication Hub, recreating environments on-a-chip to study epithelial cancer development.
Schutt Ibsen uses ultrasound waves to control the behavior of cells deep within the tissues she engineers, allowing for precise genetic changes.
It’s been 10 years since the successful completion of the Knight Cancer Challenge. Join us as we reflect on a decade of impact.
The Erik Paige Endowment for Excellence in Pediatric Oncology helps provide Doernbecher patients with dedicated and coordinated care.
OHSU is leading us into a new age of understanding a disease that has afflicted humans from the very beginning.